一种新型TRPM8抗剂的皮下注射可以逆转过敏性感冒,同时减轻核心体温下降的影响
Michael S Gold1, Jorge B Pineda-Farias1, David Close2
1Department of Neurobiology, Pittsburgh Center for Pain Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
British journal of pharmacology
|May 25, 2024
概括
这项研究表明,TRPM8抗剂VBJ103有效地治疗小鼠的寒冷过敏症. 虽然它会影响核心体温,但它的治疗潜力在疼痛管理方面仍然很有希望.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 疼痛研究 疼痛研究
背景情况:
- 暂时受体潜在的 Melastatin 8 (TRPM8) 通道与感冒和疼痛有关.
- 开发选择性TRPM8抗剂是治疗治疗疼痛的治疗目标.
- 以前的TRPM8抗剂面临挑战,包括影响核心体温 (CBT) 的副作用.
研究的目的:
- 描述TRPM8对手VBJ103,评估其选择性,有效性和对核心体温的影响.
- 评估VBJ103在化疗诱导的神经病痛的临床前模型中的治疗潜力.
- 调查VBJ103管理的安全概况和潜在责任.
主要方法:
- 对人类TRPA1和TRPV1通道进行选择性分析.
- 在体外安全性评估,包括多巴胺载体 (DAT) 抑制.
- 评估VBJ103在oxaliplatin诱导的寒冷过敏症小鼠模型中的疗效.
- 评估VBJ103对核心体温 (CBT) 的影响,通过皮下和腹腔内给药后的放射测量.
主要成果:
- VBJ103对TRPM8表现出选择性,在TRPA1和TRPV1没有对抗活性,尽管观察到低强度的TRPA1激活.
- 在接受过氧化治疗的小鼠中,VBJ103的皮下给药剂量依赖地减轻了感冒过敏.
- 系统性给予VBJ103,特别是在腹膜内,剂量取决于核心体温的下降.
- 多巴胺载体 (DAT) 的部分抑制是唯一发现的安全责任.
结论:
- VBJ103在临床前的寒冷过敏症模型中表现出治疗效果.
- 系统性给予VBJ103会影响核心体温,这是TRPM8向疗法的已知挑战.
- 进一步的研究是有必要的,以优化VBJ103的管理和缓解CBT相关的副作用临床翻译.
相关概念视频
Thermosensation
30.4K
Peripheral thermosensation is the perception of external temperature. A change in temperature (on the surface of the skin and other tissues) is detected by a family of temperature-sensitive ion channels called Transient Receptor Potential, or TRP, receptors. These receptors are located on free nerve endings. Those detecting cold temperatures are closer to the surface of the skin than the nerve endings detecting warmth. These thermoTRP channels, while temperature selective, have relatively...
30.4K
Decreased Body Temperature
612
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
612
Thermoregulation
967
The human body has a sophisticated thermoregulation system that employs negative feedback mechanisms to maintain an optimal core temperature. When the core temperature drops, peripheral and central thermoreceptors send signals to the hypothalamus, activating the heat-promoting center. This center triggers several responses aimed at increasing the core temperature. First, vasoconstriction reduces the flow of warm blood from internal organs to the skin so that the heat is not lost from the skin,...
967
Methods of reducing fever
661
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Pharmacological Methods of Reducing Fever:
661
Body Temperature
941
The body's temperature, measured in degrees, is determined by the balance between heat production and dissipation to the surrounding environment. For instance, if exercising vigorously, the body will produce more heat, causing sweat and dissipating that heat. Despite extreme environmental conditions and physical exertion, the human temperature-control system maintains a constant core body temperature (the temperature of deep tissues, which are the tissues located beneath the skin and other...
941
Mechanism of heat transfer
1.2K
Understanding heat transfer mechanisms is essential for understanding how our bodies maintain balance in different environmental conditions. When the environment is thermoneutral, the body is in a state of balance, neither using nor releasing energy to maintain its core temperature. However, when the environment is not thermoneutral, the body employs four heat transfer mechanisms to maintain homeostasis: conduction, convection, evaporation, and radiation. These mechanisms facilitate heat...
1.2K


